Electrochemical Detection of a Novel Pt(IV) Prodrug with the Metronidazole Axial Ligand in the Hypoxic Area.
暂无分享,去创建一个
V. N. Nikitina | D. Sakharov | M. Soldatov | A. Majouga | K. Y. Vlasova | A. Vaneev | A. Erofeev | D. Skvortsov | A. Trigub | R. Akasov | P. Gorelkin | E. Beloglazkina | A. Finko | N. Zyk | A. Semkina | Daniil Spector | O. Krasnovskaya | Nikolay Ul'yanovskiy
[1] V. N. Nikitina,et al. Pt(IV) Prodrugs with Non-Steroidal Anti-inflammatory Drugs in the Axial Position. , 2022, Journal of medicinal chemistry.
[2] Y. Korchev,et al. In Vitro/In Vivo Electrochemical Detection of Pt(II) Species. , 2022, Analytical chemistry.
[3] Xiuxiu He,et al. Glass Nanopipette Sensing of Single Entities , 2022, Journal of Electroanalytical Chemistry.
[4] P. Sadler,et al. Single-Cell Chemistry of Photoactivatable Platinum Anticancer Complexes , 2021, Journal of the American Chemical Society.
[5] Xiao-Yuan Wang,et al. Nanopipette-Based Nanosensor for Label-Free Electrochemical Monitoring of Cell Membrane Rupture under H2O2 Treatment. , 2021, Analytical chemistry.
[6] Yue Li,et al. Targeting Hypoxia: Hypoxia-Activated Prodrugs in Cancer Therapy , 2021, Frontiers in Oncology.
[7] G. Guo,et al. Silica-Based Nanopipettes for Rapid Living Single-Cell Transfection , 2021, ACS Applied Nano Materials.
[8] Xiaomei Yan,et al. Activatable Mitochondria-Targeting Organoarsenic Prodrugs for Bioenergetic Cancer Therapy. , 2020, Angewandte Chemie.
[9] V. N. Nikitina,et al. NOVEL COPPER-CONTAINING CYTOTOXIC AGENTS BASED ON 2-THIOXOIMIDAZOLONES. , 2020, Journal of medicinal chemistry.
[10] A. Ewing,et al. Nanoelectrochemical analysis inside a single living cell , 2020 .
[11] L. Ji,et al. CAIXplatins: highly potent Pt(IV) prodrugs selectively against hypoxic tumors via microenvironment and metabolism regulation. , 2020, Angewandte Chemie.
[12] A. Murray,et al. Real-time measurement of tumour hypoxia using an implantable microfabricated oxygen sensor , 2020, Sensing and Bio-Sensing Research.
[13] Y. Korchev,et al. In vitro and in vivo Electrochemical Measurement of ROS After Treatment with Anticancer Drugs. , 2020, Analytical chemistry.
[14] V. Gandin,et al. Expanding the Arsenal of PtIV Anticancer Agents; Multi-action PtIV Anticancer Agents with Bioactive Ligands Possessing Hydroxyl Functional Group. , 2019, Angewandte Chemie.
[15] V. Brabec,et al. Platinum (IV) Derivatives with Cinnamate Axial Ligands Are Potent Agents Against Both Differentiated and Tumorigenic Cancer Stem Rhabdomyosarcoma Cells. , 2019, Angewandte Chemie.
[16] Monilola A. Olayioye,et al. Direct impact of cisplatin on mitochondria induces ROS production that dictates cell fate of ovarian cancer cells , 2019, Cell Death & Disease.
[17] A. Murray,et al. A Dual Killing Strategy - Photocatalytic Generation of Singlet Oxygen with Concomitant Pt(IV) Prodrug Activation. , 2019, Angewandte Chemie.
[18] Kenji Hirata,et al. The Roles of Hypoxia Imaging Using 18F-Fluoromisonidazole Positron Emission Tomography in Glioma Treatment , 2019, Journal of clinical medicine.
[19] E. Khaydukov,et al. Photodynamic therapy of melanoma by blue-light photoactivation of flavin mononucleotide , 2019, Scientific Reports.
[20] E. Ragazzi,et al. Mitochondrial Involvement in Cisplatin Resistance , 2019, International journal of molecular sciences.
[21] Weihua Huang,et al. Electrochemical Monitoring of ROS/RNS Homeostasis Within Individual Phagolysosomes Inside Single Macrophages. , 2019, Angewandte Chemie.
[22] B. Keppler,et al. A Dogma in Doubt: Hydrolysis of Equatorial Ligands of PtIV Complexes under Physiological Conditions , 2019, Angewandte Chemie.
[23] G. Pastorin,et al. Dual‐Targeting Dual‐Action Platinum(IV) Platform for Enhanced Anticancer Activity and Reduced Nephrotoxicity , 2019, Angewandte Chemie.
[24] K. Zafar,et al. Comparative evaluation of Chlorhexidine, Metronidazole and combination gels on gingivitis: A randomized clinical trial , 2019, International journal of surgery protocols.
[25] Y. Long,et al. Confined Nanopipette Sensing: From Single Molecules, Single Nanoparticles, to Single Cells. , 2019, Angewandte Chemie.
[26] Keke Hu,et al. Electrochemical Measurements of Reactive Oxygen and Nitrogen Species inside Single Phagolysosomes of Living Macrophages. , 2019, Journal of the American Chemical Society.
[27] T. Hambley,et al. The reduction of cis-platinum(iv) complexes by ascorbate and in whole human blood models using 1H NMR and XANES spectroscopy. , 2019, Metallomics : integrated biometal science.
[28] R. Akasov,et al. Metformin increases antitumor activity of MEK inhibitor binimetinib in 2D and 3D models of human metastatic melanoma cells. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[29] Elisabete C Costa,et al. 3D tumor spheroids as in vitro models to mimic in vivo human solid tumors resistance to therapeutic drugs , 2018, Biotechnology and bioengineering.
[30] A. Majouga,et al. Prolonged oxygen depletion in microwounded cells of Chara corallina detected with novel O2 nanosensors. , 2019, Journal of experimental botany.
[31] Xun Hu,et al. N, S, P-Triple Doped Porous Carbon as an Improved Electrochemical Sensor for Metronidazole Determination , 2019, Journal of The Electrochemical Society.
[32] Zijian Guo,et al. Impact of Mitochondrion-Targeting Group on the Reactivity and Cytostatic Pathway of Platinum(IV) Complexes. , 2018, Inorganic chemistry.
[33] Rong Ma,et al. Monochalcoplatin: An Actively Transported, Quickly Reducible, and Highly Potent PtIV Anticancer Prodrug. , 2018, Angewandte Chemie.
[34] Nader Pourmand,et al. Nanopipettes as Monitoring Probes for the Single Living Cell: State of the Art and Future Directions in Molecular Biology , 2018, Cells.
[35] Yongfeng Zhou,et al. Oxygen and Pt(II) self-generating conjugate for synergistic photo-chemo therapy of hypoxic tumor , 2018, Nature Communications.
[36] Y. Korchev,et al. Novel method for rapid toxicity screening of magnetic nanoparticles , 2018, Scientific Reports.
[37] Masafumi Nakamura,et al. Combined Gemcitabine and Metronidazole Is a Promising Therapeutic Strategy for Cancer Stem-like Cholangiocarcinoma. , 2018, Anticancer research.
[38] Keke Hu,et al. Direct Electrochemical Measurements of Reactive Oxygen and Nitrogen Species in Nontransformed and Metastatic Human Breast Cells. , 2017, Journal of the American Chemical Society.
[39] A. Najjar,et al. Recent Approaches to Platinum(IV) Prodrugs: A Variety of Strategies for Enhanced Delivery and Efficacy. , 2017, Current pharmaceutical design.
[40] Koji Okamoto,et al. Tumor‐derived spheroids: Relevance to cancer stem cells and clinical applications , 2017, Cancer science.
[41] Hossein Tavana,et al. Engineered Breast Cancer Cell Spheroids Reproduce Biologic Properties of Solid Tumors , 2016, Advanced healthcare materials.
[42] L. Morrison,et al. Oxidative Stress Induced by Pt(IV) Pro-drugs Based on the Cisplatin Scaffold and Indole Carboxylic Acids in Axial Position , 2016, Scientific Reports.
[43] Meareg Amare,et al. Electrochemical Determination of Metronidazole in Tablet Samples Using Carbon Paste Electrode , 2016, Journal of analytical methods in chemistry.
[44] E. Yavin,et al. On the stability of Pt(IV) pro-drugs with haloacetato ligands in the axial positions. , 2015, Chemistry.
[45] S. Dhar,et al. Detouring of cisplatin to access mitochondrial genome for overcoming resistance , 2014, Proceedings of the National Academy of Sciences.
[46] David Robert Grimes,et al. A method for estimating the oxygen consumption rate in multicellular tumour spheroids , 2014, Journal of The Royal Society Interface.
[47] S. Dhar,et al. The prodrug platin-A: simultaneous release of cisplatin and aspirin. , 2014, Angewandte Chemie.
[48] David Klenerman,et al. Electrochemical nanoprobes for single-cell analysis. , 2014, ACS nano.
[49] T. Hambley,et al. Influence of equatorial and axial carboxylato ligands on the kinetic inertness of platinum(IV) complexes in the presence of ascorbate and cysteine and within DLD-1 cancer cells. , 2013, Journal of medicinal chemistry.
[50] S. Lippard,et al. Redox activation of metal-based prodrugs as a strategy for drug delivery. , 2012, Advanced drug delivery reviews.
[51] M. Hall,et al. Quantitative measurement of the reduction of platinum(IV) complexes using X-ray absorption near-edge spectroscopy (XANES). , 2012, Metallomics : integrated biometal science.
[52] Jean-Marc Noël,et al. Nanoelectrodes for determination of reactive oxygen and nitrogen species inside murine macrophages , 2012, Proceedings of the National Academy of Sciences.
[53] M. A. De Luca,et al. Metronidazole prodrugs: synthesis, physicochemical properties, stability, and ex vivo release studies. , 2011, European journal of medicinal chemistry.
[54] C. Nord,et al. Metronidazole is still the drug of choice for treatment of anaerobic infections. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[55] G. Karcher,et al. Measurement of hypoxia using invasive oxygen-sensitive electrode, pimonidazole binding and 18F-FDG uptake in anaemic or erythropoietin-treated mice bearing human glioma xenografts. , 2008, International journal of oncology.
[56] D. Gibson,et al. Reduction of cis,trans,cis-[PtCl2(OCOCH3)2(NH3)2] by aqueous extracts of cancer cells. , 2007, Journal of medicinal chemistry.
[57] Celia Quevedo,et al. Biochemical mechanisms of cisplatin cytotoxicity. , 2007, Anti-cancer agents in medicinal chemistry.
[58] David J. Yang,et al. PET and planar imaging of tumor hypoxia with labeled metronidazole. , 2006, Academic radiology.
[59] M. McKeage,et al. Satraplatin activation by haemoglobin, cytochrome C and liver microsomes in vitro , 2006, Cancer Chemotherapy and Pharmacology.
[60] M. Jakupec,et al. Update of the preclinical situation of anticancer platinum complexes: novel design strategies and innovative analytical approaches. , 2005, Current medicinal chemistry.
[61] K. Tan,et al. Metronidazole induces programmed cell death in the protozoan parasite Blastocystis hominis. , 2004, Microbiology.
[62] Z. Siddik,et al. Cisplatin: mode of cytotoxic action and molecular basis of resistance , 2003, Oncogene.
[63] M. Hall,et al. XANES determination of the platinum oxidation state distribution in cancer cells treated with platinum(IV) anticancer agents. , 2003, Journal of the American Chemical Society.
[64] Sunhee Choi,et al. Reduction and Anticancer Activity of Platinum(IV) Complexes , 1998 .
[65] K. Lamp,et al. Metronidazole. A therapeutic review and update. , 1997, Drugs.
[66] C. Koch,et al. Oxygen dependence of cellular uptake of EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)a cet amide] : analysis of drug adducts by fluorescent antibodies vs bound radioactivity. , 1995, British Journal of Cancer.
[67] L. Dittert,et al. Acetaminophen prodrugs. I. Synthesis, physicochemical properties, and analgesic activity. , 1968, Journal of pharmaceutical sciences.